跳至主要内容
临床试验/NCT01383122
NCT01383122终止不适用

The Efficacy of Pulsed Electromagnetic Field Therapy for Management of Post-operative Pain Following Cesarean Delivery: a Randomised, Double-blind, Placebo-controlled Study

Samuel Lunenfeld Research Institute, Mount Sinai Hospital2 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2011年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
125
试验地点
2
主要终点
Pain score by visual analogue scale (VAS) on movement at 48 hours postoperatively

研究概览

简要总结

Pain following Cesarean delivery remains the most common post-operative complaint, and the provision of effective and safe analgesia is very important. Pain can impede the mother's ability to mobilise, and to care for and breastfeed her newborn baby.

Pulsed electromagnetic field (PEMF) devices have been used in various clinical settings, especially after plastic surgeries, to reduce postoperative swelling and pain, as well as to accelerate wound repair. PEMF therapy is simple to use, cost-effective and has no known side effects.

Despite advances in post-operative analgesia, pain relief and maternal satisfaction remain inadequate in some patients. Improving the quality of post-Cesarean analgesia while limiting undesirable side effects will enhance maternal satisfaction and reduce the risk of post-operative complications.

The investigators hypothesize that the continuous use of a PEMF device for 48 hours after Cesarean delivery will result in decreased post-operative pain scores on movement at 48 hours.

详细描述

Currently, at our institution, analgesic regimens are multimodal, in that they combine analgesic drugs with differing mechanisms of action, with the aim of producing effective analgesia while minimising adverse effects. They include opioid drugs, administered both neuro-axially and systemically, as well as paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs). Opioids, while effective, have significant adverse effects, including sedation, nausea, vomiting and constipation. Non-steroidal anti-inflammatory drugs (NSAIDs) can reduce opioid consumption, but also have side effects, and are contra-indicated in a significant number of patients. Therefore there remains considerable scope to improve post-Cesarean analgesia.

Pulsed electromagnetic field (PEMF) technology relieves edema, inflammation and pain by stabilizing leaking cell membranes. The short bursts of electrical current do not produce heat or interfere with nerve or muscle function. The pulsed energy drives out edematous fluid along with by-products of the damaged tissue, which reduces swelling and helps re-establish cell-cell communication. The device is easily applied over the wound dressing, and has no known side effects for either the mother or the infant.

As the rate of Cesarean delivery continues to increase, and there remain significant problems with current analgesic regimens, the use of pulsed electromagnetic field therapy has the potential to considerably improve acute and chronic post-Cesarean pain management, and lead to a widespread change in clinical practice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18 years or older
  • full term singleton pregnancy
  • undergoing elective cesarean delivery

排除标准

  • Patients who have refused, are unable to give or have withdrawn consent
  • Patients unable to communicate fluently in English
  • Patients with American Society of Anesthesiologists (ASA) classification of 3 or greater
  • Patients with chronic pain, or neuropathic analgesic drugs
  • Patients in use of antidepressant and psychotropic drugs
  • Patients with a history of opioid or intravenous drug abuse
  • Patients with known allergy or contra-indication to any other drugs used in this trial
  • Patients who have refused spinal anesthesia, or those in whom it is contra-indicated
  • Patients with a history of previous cesarean delivery and persistent pain

研究组 & 干预措施

Active device

Active Comparator

Functional pulsed electromagnetic field device

干预措施: Pulsed electromagnetic field device (ActiPatch TM) (Device)

Placebo - inactive device

Placebo Comparator

Inactive pulsed electromagnetic field device

干预措施: Inactive pulsed electromagnetic field device (ActiPatch TM) (Device)

结局指标

主要结局

Pain score by visual analogue scale (VAS) on movement at 48 hours postoperatively

时间窗: 48 hours

次要结局

  • Presence of pain 6 weeks postoperatively(6 weeks)
  • Assessment of side effects: nausea, vomiting, sedation & itchiness(48 hours)
  • Pain at rest and on movement by VAS, and maternal satisfaction at 24 & 48 hours postoperatively(48 hours)
  • Opioid consumption at 24 & 48 hours postoperatively(48 hours)

研究者

发起方
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
申办方类型
Other

研究点 (2)

Loading locations...

相似试验